Trial Breast Cancer Drug Shows 'Modest' Benefit

As the researchers explained, taselisib has already proven beneficial for people fighting head-and-neck cancers or certain gynecological tumors. Would it do the same for hormone-sensitive breast cancers?
Source: WebMD Health - Category: Consumer Health News Source Type: news